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Abstract
Background: To identify correlates of adherence to colorectal cancer (CRC) screening guidelines
in average-risk Canadians.
Methods: 2003 Canadian Community Health Survey Cycle 2.1 respondents who were at least 50
years old, without past or present CRC and living in Ontario, Newfoundland, Saskatchewan, and
British Columbia were included. Outcomes, defined according to current CRC screening
guidelines, included adherence to: i) fecal occult blood test (FOBT) (in prior 2 years), ii) endoscopy
(colonoscopy/sigmoidoscopy) (prior 10 years), and iii) adherence to CRC screening guidelines,
defined as either (i) or (ii). Generalized estimating equations regression was employed to identify
correlates of the study outcomes.
Results:  Of the 17,498 respondents, 70% were non-adherent CRC screening to guidelines.
Specifically, 85% and 79% were non-adherent to FOBT and endoscopy, respectively. Correlates for
all outcomes were: having a regular physician (OR = (i) 2.68; (ii) 1.91; (iii) 2.39), getting a flu shot
(OR = (i) 1.59; (ii) 1.51; (iii) 1.55), and having a chronic condition (OR = (i) 1.32; (ii) 1.48; (iii) 1.43).
Greater physical activity, higher consumption of fruits and vegetables and smoking cessation were
each associated with at least 1 outcome. Self-perceived stress was modestly associated with
increased odds of adherence to endoscopy and to CRC screening guidelines (OR = (ii) 1.07; (iii)
1.06, respectively).
Conclusion: Healthy lifestyle behaviors and factors that motivate people to seek health care were
associated with adherence, implying that invitations for CRC screening should come from sources
that are independent of physicians, such as the government, in order to reduce disparities in CRC
screening.
Background
In Canada, colorectal cancer (CRC) is the third most com-
monly diagnosed cancer in men and women and the sec-
ond leading cause of cancer deaths [1]. According to the
2006 Canadian Cancer statistics, an estimated 1 in 14
men and 1 in 16 women will develop CRC in their life-
times and 1 in 28 men and 1 in 31 women will die from
CRC. CRC screening reduces both CRC incidence through
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removal of premalignant polyps and CRC deaths through
early detection and treatment. Since 1996, Canadian and
U.S. organizations have published guidelines for CRC
screening in individuals who are 50 years of age and older
and at average-risk for developing the disease [2-6]. Rec-
ommendations include performance of either annual or
biannual FOBT, flexible sigmoidoscopy every 5 years,
double contrast barium enema every 5 to 10 years or
colonoscopy every 10 years.
Although routine CRC screening can reduce incidence,
morbidity and mortality from the disease, CRC screening
in Canada is suboptimal [7-9]. Most (58% to 92%) physi-
cians report recommending CRC screening to average-risk
patients [10-12] and undergoing screening themselves,
mainly with colonoscopy [13]. But the best case scenario,
estimated from survey data, is that 23% of the screen-eli-
gible population has ever been screened [8] and that 53%
of Canadian physicians have undergone CRC screening
[13]. These physician rates are comparable to rates for the
CRC screen-eligible population in the U.S., which range
between 38% and 54% [14,15]. Yet there are methodolog-
ical challenges to estimating population CRC screening
rates. The universal access, publicly funded health care
systems in the Canadian provinces collect information on
performance of large bowel procedures, but do not collect
information on use of FOBT. This is problematic because
FOBT and colonoscopy are the two procedures most often
performed for CRC screening. Surveys, by comparison,
commonly supply data on FOBT but rely on self-report.
Whereas self-report could be problematic for distinguish-
ing between sigmoidoscopy and colonoscopy, independ-
ent studies show good sensitivity and specificity for self-
reported procedural use, especially when sigmoidoscopy
and colonoscopy are grouped together[16,17].
Health Canada considers CRC ideal for mass screening of
average individuals [18]. However, because population-
based CRC screening programs are only now, in 2007,
being established, most referrals for CRC screening
occurred in primary care practices, which are major sites
for providing health promotion and screening services.
Not surprising, studies consistently report associations
between receipt of a physician referral for CRC screening
[19-24] and adherence to CRC screening guidelines.
Other patient characteristics associated with this outcome
include older age[20,25,26], sex[20,22], higher social
class[26,27], White race [21,28], having health insurance
[26] or usual source of health care[26,29], family history
of CRC[30], higher education[26], higher socioeconomic
status[26,27,31], knowledge of CRC[19-24,32], perceived
risk of developing CRC [19-24] and adhering to other pre-
ventive health behaviours[25,30,33].
Given the limited knowledge about CRC screening in
Canada and the variability in physician referral behav-
iour, we sought to evaluate adherence to CRC screening
guidelines by utilizing data from a national survey. The
purpose of this study was to identify individual and health
system level characteristics associated with adherence to
CRC screening guidelines in average-risk residents of
Newfoundland, Ontario, Saskatchewan and British
Columbia. We employed a biopsychosocial framework,
which integrates biomedical, psychosocial and environ-
mental factors, to better understand disparities in adher-
ence to CRC screening guidelines. Elucidating the factors
associated with adherence to CRC screening guidelines
may help tailor interventions aimed at improving utiliza-
tion of CRC screening.
Methods
Data sources
The principal data source for this evaluative population-
based study was the Statistics Canada 2003 Canadian
Community Health Survey (CCHS) Cycle 2.1. The CCHS
targeted persons aged 12 years and older who were living
in private dwellings in all Canadian provinces and territo-
ries. Exclusions included individuals living on Indian
reserves, institutional residents, full-time members of the
Canadian Armed Forces and residents of certain remote
regions. Survey methods employed either personal or tel-
ephone interviews using a questionnaire designed for
computer-assisted interviewing and have been describe
elsewhere in greater detail[18]. In both interview proc-
esses, complex multi-step strategies were used to maxi-
mize response rates; an overall national response rate of
80.7% was achieved.
The CCHS Cycle 2.1 survey data consisted of non-nomi-
native information on health status, health determinants
and health care utilization. Some information was asked
of all respondents, while other information was asked of
a sub-sample of respondents large enough to generate reli-
able provincial and national estimates. Optional informa-
tion was asked of all respondents in selected health
regions. The CRC screening module was optional, and
administered to approximately 40,000 individuals in all
health regions of Newfoundland and British Columbia
and in 14 of 37 and 7 of 11 health regions of Ontario and
Saskatchewan, respectively[34]. Health regions are
defined as legislated administrative areas representing
geographic areas of responsibility for hospital boards or
regional health authorities[35].
Secondary data sources were the provincial medical asso-
ciations and health insurance boards of the provinces
included in this study. These data sources provided health
system level information on provincial per capita num-BMC Gastroenterology 2007, 7:39 http://www.biomedcentral.com/1471-230X/7/39
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bers of gastroenterologists and general practitioners and
provincial endoscopist fees.
Study population
A total of 130,000 respondents were surveyed from health
regions of all provinces and territories between January
and December 2003[18]. Study subjects were respondents
who completed the CRC screening module and were at
average-risk for developing CRC. For the purpose of the
present study, average risk respondents were defined as
those who were at least 50 years of age, without past or
present CRC.
Independent study variables
Socio-demographic and lifestyle characteristics included age,
sex, education, country of birth, cultural/racial origin,
daily servings of fruits and vegetables, number of alco-
holic drinks in the past week, household income, employ-
ment status and participation in physical activities in the
past 3 months. Clinical characteristics included self-per-
ceived general health, smoking status, chronic conditions,
having a regular physician, bowel disease (Crohn's dis-
ease, ulcerative colitis), receipt of flu shots (over lifetime).
Psychosocial characteristics included self-perceived mental
health, life satisfaction, self-perceived stress and self-per-
ceived work stress. Environmental characteristics included
residential area, health region of residence, province, pro-
vincial per capita numbers of gastroenterologists and gen-
eral practitioners in 2003, and provincial endoscopist fees
(based on 2003 colonoscopy fees).
Outcomes
Four adherence outcomes were defined based on reported
use of FOBT and endoscopy (sigmoidoscopy or colonos-
copy). Ever use was equal to 1 if the respondent ever had
either an FOBT or an endoscopy and was equal to 0 oth-
erwise. Adherence to FOBT screening guidelines was defined
has having an FOBT within the past 2 years. Adherence to
endoscopy screening guidelines was defined as undergoing
endoscopy in the past 10 years. Adherence to current CRC
screening guidelines was defined as having adherence to
either FOBT or endoscopy as just defined. These variables
were coded as binary with 1 indicating adherence and 0
non-adherence. The criteria used to define the adherence
outcomes were consistent with CRC screening recommen-
dations in place in 2003.
Statistical analyses
Descriptive statistics were used to characterize the study
population. We used Generalized Estimating Equations
(GEE) regression[36] and backward elimination (Statisti-
cal Analysis System (SAS) GENMOD procedure [37]) to
identify the socio-demographic, lifestyle, clinical, psycho-
social and environmental correlates of the four study out-
comes. The GEE approach accounts for clustered data
(possible correlations of outcomes of respondents in the
same health region) and for the unbalanced structure of
the data, as the number of respondents varied across prov-
inces or health regions. Province was a four-level fixed
effect (Newfoundland, Ontario, Saskatchewan, British
Columbia). Provincial per capita numbers of gastroenter-
ologists and general practitioners and endoscopist fees
(10$ increment) were treated as continuous variables.
Provincial variables did not vary within province (for
example provincial endoscopist fee is the same for all peo-
ple in a province) and, therefore, could not be entered
together with province into the same regression model.
Respondents with bowel disease were excluded from the
regression analyses as use of FOBT and endoscopy may
have been performed for disease surveillance. Multiple
imputation was performed (SAS MI procedure version
9.1.3) to account for missing variables values (28.9% of
respondents had at least 1 missing value). The final mod-
els contained only significant variables (p-values around
0.05 or less). Odds ratios (OR) and 95% confidence inter-
vals (95%CI) were obtained by exponentiating the param-
eter estimates. All results presented in this paper represent
weighted values, in keeping with the regulations of Statis-
tics Canada. Population sample weights and bootstraps
weights provided by Statistics Canada were used to pro-
duce estimates for all variables. Because the CCHS Cycle
2.1 sample design was complex, sample weights were
used to account for the unequal probability of selection of
individuals in the different provinces into the survey.
Sample weights are based on the probability of selection
into the survey and adjust for possible bias resulting from
non-response[38]. Two-tailed p-values less than 0.05 were
considered to be statistically significant. Ethical approval
from the Research Ethics Board of the Research Institute of
the McGill University Health Centre and permission from
Statistics Canada were obtained prior to study inception.
Results
A total of 17,498 eligible respondents, representing
2,529,577 Canadians, comprise the study population.
Table 1 presents the socio-demographic, lifestyle, clinical,
psychological and environmental characteristics of the
study population. The majority of respondents were:
female, aged 50–64, post-secondary school graduates,
born in Canada, White, physically inactive, not employed,
former smokers, without bowel disease, resided in British
Columbia and lived in urban areas. Most had a chronic
condition, a regular medical doctor and received a flu
shot. Table 2 presents rates of non-adherence. Most
(58.3%) respondents had never received either FOBT or
endoscopy. Specific rates of non-adherence were 84.9%
for FOBT, 79.4% for endoscopy and 69.9% for current
CRC screening guidelines.BMC Gastroenterology 2007, 7:39 http://www.biomedcentral.com/1471-230X/7/39
Page 4 of 9
(page number not for citation purposes)
Table 1: Socio-demographic, lifestyle, clinical, psychological and environmental characteristics of the study population (N* = 17,498)
Characteristic Category N %a
Socio-demographic/lifestyle
Sex male 1208664 47.8
female 1320913 52.2
Age 50–64 1479850 58.5
65+ 1049727 41.5
Education < high school 689570 28.1
high school grad. 487774 19.9
post-high school 146537 6.0
post-high school grad. 1132259 46.1
Country of birth Canada 1727948 69.7
other 750832 30.3
Cultural/racial origin White 2174040 87.7
other 303954 12.3
Household income low-low medium 696891 33.5
upper medium 720335 34.6
high 661775 31.8
Fruits & vegetables - mean = 4.99 sd = 2.32
Number of alcoholic drinks - mean = 3.04 sd = 5.78
Physical activity active 584365 24.2
moderate 625280 25.9
inactive 1205071 49.9
Employment status full-time 889514 36.1
part-time 216564 8.8
no job 1357573 55.1
Clinical
Self-perceived general healthb excellent – poor mean = 2.6 sd = 1.1
Smoking status current 399069 15.9
former 1305483 52.0
never 804093 32.1
Bowel disease yes 90678 3.6
no 2434886 96.4
Chronic condition yes 2129661 84.4
no 393254 15.6
Regular physician yes 2393987 94.7
no 134991 5.3
Flu shot yes 1516797 62.7
no 902214 37.3
Psychosocial
Self-perceived mental healthb excellent – poor mean = 2.0 sd = 0.9
Life satisfaction b very satis. – very dissatis. mean = 1.7 sd = 0.8
Self-perceived stress b not at all – extremely mean = 2.5 sd = 1.1
Self-perceived work stressb not at all – extremely mean = 2.9 sd = 1.0
Environmental
Health region 43 regions - -
Provincec NF & B 163555 6.5
ON 946484 37.4
SK 178713 7.1
BC 1240825 49.1
Residential area urban 2002811 79.2
rural 526765 20.8BMC Gastroenterology 2007, 7:39 http://www.biomedcentral.com/1471-230X/7/39
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Table 3 presents the results of the multivariate models for
the four CRC screening outcomes. The final models
included sex, age, country of birth, ethnic/cultural back-
ground, household income, physical activity, employ-
ment, fruit and vegetable consumption, smoking status,
chronic condition, having a regular physician, flu shot,
self-perceived stress and province. Ever use was associated
with older age, born in Canada, White race, high income
level, active/moderate physical activity, not employed,
increased consumption of fruits and vegetables, former
smoker, having: a chronic disease, a regular physician, a
flu shot, higher self-perceived stress and residing in
Ontario. Adherence to FOBT screening guidelines was associ-
ated with male sex, high income level, active/moderate
physical activity, not employed full-time, increased con-
sumption of fruits and vegetables, and having: a chronic
condition, a regular physician, and a flu shot. Residents of
Newfoundland were less likely than those in British
Columbia to adhere to FOBT screening guidelines. Adher-
ence to endoscopy screening guidelines was associated with
born in Canada, White race, not employed, former
smoker, having: a chronic disease, a regular physician, a
flu shot, higher self-perceived stress, and residing in New-
foundland or Ontario. Adherence to current CRC screening
guidelines was associated older age, born in Canada, White
race, high income level, active/moderate physical activity
level, not employed, former smoker, having: a chronic
condition, a regular physician, a flu shot, higher self-per-
ceived stress and residing in Ontario. When provincial
variables rather than province were included in the mod-
els, lower endoscopist fees were linearly associated with
adherence to endoscopy screening guidelines (data not
shown).
Discussion
This population-based study showed low utilization of
CRC screening in Canadians, with 58% of the study pop-
ulation having never received either FOBT or endoscopy.
Of importance, 70% of respondents were not adherent to
current CRC screening guidelines; specifically, 85% had
not received FOBT within the last 2 years and 80% had
not received endoscopy within the last 10 years. Not only
were the majority of Canadians not screened for CRC, but
also most of those who had undergone these procedures
did not do so according to current recommendations. Our
results mirror those reported by other Canadian studies.
Provincial NF & B ON SK BC
Number gastroenterologistsd 1.55 1.23 0.40 1.00
Number general practitionerse 1.24 0.83 1.05 1.10
Endoscopist fees f 125$ 57$ 143$ 179$
All numbers are weighted
*Number of respondents representing 2,529,577 Canadians
a Percentage based on valid responses (excludes missing values)
b Based on 5-item rating scale
c NF & LB = Newfoundland and Labrador; ON = Ontario; SK = Saskatchewan; BC = British Columbia
d Number gastroenterologists per 100,000
e Number general practitioners per 1,000
f Fees based on 2003 physician remuneration for colonoscopy performance
Table 1: Socio-demographic, lifestyle, clinical, psychological and environmental characteristics of the study population (N* = 17,498) 
Table 2: Frequency of the four adherence outcomes (N* = 17,498)
Outcome Category N %a
Ever use yes 999841 41.7
no 1395604 58.3
Adherence to FOBT screening 
guidelines
yes 356535 15.1
no 2005605 84.9
Adherence to endoscopy 
screening guidelines
yes 490128 20.6
no 1890047 79.4
Adherence to current CRC 
screening guidelines
yes 720899 30.1
no 1673225 69.9
All numbers are weighted
*Number of respondents representing 2,529,577 Canadians
a Percentage of valid responses (excludes missing values)
FOBT = fecal occult blood test
CRC = colorectal cancerB
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Table 3: Socio-demographic, lifestyle, clinical, psychological and environmental characteristics that discriminate between the four adherence outcomes (N = 16,791* **)
Ever use Adherence to FOBT 
screening guidelines
Adherence to 
endoscopy screening guidelines
Adherence to current 
CRC screening guidelines
Characteristic Category OR 95%CI p value OR 95%CI p value OR 95%CI p value OR 95%CI p value
Sex female 0.71 0.57–0.88 0.0021
male 1 .
Age 50–64 0.82 0.72–0.93 0.0023 0.93 0.79–1.10 0.4002 0.92 0.80–1.06 0.2648 0.89 0.82–0.98 0.0168
65 + 1 1 1 1
Country of birth Canada 1.12 1.00–1.26 0.0599 1.27 1.13–1.43 0.0001 1.13 1.01–1.27 0.0279
other 1 1 1
Cultural/racial origin White 1.64 1.29–2.07 <.0001 1.33 1.05–1.70 0.0192 1.42 1.12–1.81 0.0043
other 1 1 1
Household income low 0.87 0.78–0.97 0.0113 0.82 0.72–0.93 0.0016 0.84 0.76–0.93 0.0005
medium 0.99 0.90–1.09 0.8629 0.93 0.81–1.06 0.2623 0.96 0.88–1.04 0.2724
high 1 1 1
Physical activity active 1.25 1.09–1.43 0.0017 1.37 1.15–1.62 0.0003 1.25 1.08–1.45 0.0035
moderate 1.23 1.13–1.34 <.0001 1.21 1.04–1.41 0.0143 1.20 1.08–1.33 0.0005
not active 1 1 . 1
Employment full-time 0.70 0.61–0.81 <.0001 0.73 0.62–0.87 0.0004 0.83 0.73–0.95 0.0063 0.76 0.67–0.87 <.0001
part-time 0.87 0.73–1.05 0.1516 0.84 0.69–1.03 0.0910 0.87 0.69–1.11 0.2568 0.81 0.68–0.98 0.0282
no job 1 1 1 1
Fruits & vegetables - 1.03 1.01–1.05 0.0025 1.05 1.03–1.06 <.0001 1.02 1.00–1.05 0.0667
Smoking status current 0.91 0.78–1.06 0.2077 0.85 0.65–1.11 0.2292 0.84 0.71–1.00 0.0537 0.83 0.70–0.98 0.0241
former 1.21 1.11–1.33 <.0001 1.10 0.94–1.29 0.2496 1.20 1.06–1.36 0.0042 1.19 1.07–1.33 0.0021
never 1 1 1 1
Chronic condition yes 1.49 1.28–1.74 <.0001 1.32 1.11–1.57 0.0021 1.48 1.20–1.82 0.0002 1.43 1.25–1.63 <.0001
no 1 1 1 1
Regular physician yes 1.81 1.50–2.18 <.0001 2.68 1.77–4.04 <.0001 1.91 1.46–2.50 <.0001 2.39 1.87–3.03 <.0001
no 1 1 1 1
Flu shot yes 1.61 1.47–1.78 <.0001 1.59 1.39–1.82 <.0001 1.51 1.37–1.66 <.0001 1.55 1.41–1.70 <.0001
no 1 1 1 1
Self-perceived stress - 1.10 1.05–1.15 <.0001 1.07 1.01–1.12 0.0132 1.06 1.01–1.11 0.0162
Provincea NF & B 0.96 0.78–1.17 0.6547 0.61 0.37–0.99 0.0463 1.35 1.05–1.73 0.0189 1.02 0.84–1.23 0.8474
ON 1.28 1.03–1.59 0.0284 1.39 0.85–2.28 0.1928 1.42 1.22–1.64 <.0001 1.43 1.13–1.80 0.0025
SK 1.14 0.76–1.73 0.5190 1.27 0.74–2.16 0.3821 1.19 0.92–1.53 0.1803 1.18 0.76–1.82 0.4602
BC 1 1 1 1
Significant p-values are bolded
*Number of respondent representing 2,438,766 Canadians
a NF & LB = Newfoundland and Labrador; ON = Ontario; SK = Saskatchewan; BC = British Columbia
**Respondents with bowel disease were excluded from analysisBMC Gastroenterology 2007, 7:39 http://www.biomedcentral.com/1471-230X/7/39
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For example, in 2005, 77% of surveyed Ontarians 50 years
of age and over without CRC had never been screened for
CRC[8], and close to 80% of screen-eligible Ontario ben-
eficiaries failed to receive CRC screening during a 6 year
follow-up period[7].
Socio-demographic characteristics were associated with
adherence to FOBT screening guidelines in this and other
studies, including male sex[23,30,39-41] and highest
income level [42], which were associated with increased
adherence. Whereas other studies showed an opposite
trend concerning gender differences, with women being
more likely to receive FOBT and/or less likely to receive
the invasive large bowel procedures [43-46], it nonethe-
less remains that adherence to CRC screening guidelines is
low. In the present study, working full-time was associ-
ated with poorer adherence outcomes, perhaps because of
the time commitments involved in preparing for and per-
forming CRC screening[40,47]. FOBT requires that people
adhere to dietary restrictions prior to testing while endos-
copy involves a preparation of bowel cleaning and, often,
sedation during the procedure. Alternatively, persons who
were not employed may have been ill and sought more
frequent health care compared to those who were
employed, increasing the chance of being sent for screen-
ing. Individuals who were born in Canada and White were
more likely to adhere to endoscopy screening guidelines,
similar to other studies[31,46,48,49]. Collectively, these
findings reinforce the need to tailor CRC screening inter-
ventions to underserved groups in order to decrease gaps
in CRC screening utilization.
Healthy lifestyle behaviors as well as factors that motivate
people to seek health care were associated with adherence
to CRC screening guidelines. For example, having a regu-
lar physician, a chronic condition and a flu shot were
associated with all adherence outcomes while increased
physical activity, smoking cessation and increased con-
sumption of fruits and vegetables were associated with at
least two outcomes. Because people who visit their physi-
cians less frequently may be at risk for not receiving rec-
ommended preventive health care, referrals or invitations
for CRC screening should come from a source that is inde-
pendent of physician visits, such as the government.
Moreover, as public awareness has contributed to the
adoption of healthy lifestyle practices, increasing public
knowledge of CRC screening may be a vehicle for improv-
ing CRC screening rates.
Environmental characteristics such as lower endoscopist
fees were only modestly associated with adherence to
endoscopy screening guidelines, suggesting that financial
incentives do not influence physician referral for endos-
copy, possibly because referrals are delivered by primary
care physicians. The per capita numbers of gastroenterol-
ogists and family physicians did not influence any of the
four CRC screening study outcomes. Inasmuch as number
of practicing physicians varied widely among provinces,
our findings suggest that availability and access to screen-
ing services, particularly to gastroenterologists that per-
form colonoscopy, do not influence adherence to CRC
screening guidelines in Canada. This finding is further
underscored by the lack of association between residential
area (urban/rural) and the adherence outcomes. Whereas
this finding parallels that found in Alberta[9], it is in con-
trast to others that suggest that service availability, espe-
cially for the invasive large bowel procedures, affects
utilization [46,50].
Systematic differences in CRC screening utilization were
observed among the four provinces. Respondents in Brit-
ish Columbia were least likely to adhere to endoscopy and
to current screening guidelines, while respondents in
Newfoundland were least likely to have ever used or
adhere to FOBT screening guidelines. These findings were
independent of both financial incentives and number of
practitioners who could offer or perform screening, sug-
gesting provincial incentives or disincentives to providing
CRC screening to residents may be operative. In fact, of
the four provinces included in this study, only Ontario,
which had the highest proportion of adherent residents,
recently launched a CRC screening program [51]. Likewise
Alberta and Manitoba have also recently launched CRC
screening programs[52,53].
Across provinces, self-perceived stress was independently
associated with ever use of FOBT and endoscopy, adher-
ence to endocosopy screening guidelines and adherence
to current CRC screening guidelines. It may well be that,
like individuals with a regular physician or a chronic con-
dition, stressed individuals seek frequent health care that
increases their chance for receiving preventive health serv-
ices. Similarly, patients who are among the worried well,
who perceive themselves to be at high risk for CRC, may
ask their physicians to be referred for screening. Whereas
the reverse scenario may also be true, that individuals may
be stressed as a psychological consequence of screening,
this seems less plausible because self-perceived stress was
not associated with adherence to FOBT screening guide-
lines, a test with a high false positive rate[54].
Study limitations and strengths should be considered in
the interpretation of our results. The major limitation is
cross-sectional design that precludes determining the
directionality of associations between variables. Individu-
als who underwent sigmoidoscopy beyond the recom-
mended 5-year interval were considered adherent to
endoscopy as the survey did not distinguish between sig-
moidoscopy and colonoscopy. Survey data were obtained
by self-report and not validated. All procedural indica-BMC Gastroenterology 2007, 7:39 http://www.biomedcentral.com/1471-230X/7/39
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tions, including procedures done as part of a regular
check-up/routine screening, or because of age, race, family
history of CRC or follow-up to a previous problem, were
considered in the adherence outcomes. Procedures that
may have been diagnostic (i.e. follow-up to a previous
problem) were not excluded because once the procedure
is performed, it would not have to be repeated for another
2 (FOBT) or 10 (endsocopy) years regardless of the initial
indication. Lastly, although some of the demographics of
our sample are similar to those of the entire Canadian
population (% female: 52 vs. 51; % rural residents: 21 vs.
19) our findings may not be generalizable to provinces
that were not included in the CCHS survey or where only
some health regions were included. Study strengths
include the following: 1) adherence was defined broadly
so as not to exclude individuals screened according to U.S.
guidelines; 2) the study population was restricted to aver-
age-risk individuals, the group targeted for CRC screening;
3) use of a biopsychosocial approach to examine relation-
ships between individual and health system level factors
and adherence to CRC screening guidelines, 4) inclusion
of health system level variables obtained from provincial
organizations to enhance interpretability of geographical
variation in utilization of CRC screening; and 5) findings
are likely to be representative of current practice because
only 3.2% of Canadians move out of province annually
[55].
Conclusion
In conclusion, only 30% of Canadians 50 years of age and
older received FOBT and endoscopy according to current
CRC screening guidelines whereas 58% had never
received either procedure. Healthy lifestyle behaviors and
characteristics that motivate people to seek health care
were associated with adherence to CRC screening guide-
lines. By comparison, information on provincial level sys-
tem factors, such as number of clinicians and endoscopy
costs did not contribute substantially to adherence. Inas-
much as healthier people and those who did not seek
health care were at risk for non-adherence to CRC screen-
ing guidelines, invitations for CRC screening should come
from a source that is independent of physician visits in
order to reduce CRC screening disparities in the popula-
tion. These findings may assist decision and policy-mak-
ers in planning for provision of preventive services for
CRC. Moreover, researchers may use the findings to tailor
and evaluate interventions aimed at improving rates of
CRC screening.
Abbreviations
CCHS Canadian Community Health Survey
CRC colorectal cancer
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